Poalim Equity

www.poalimequity.com/en ; www.poalimequity.com/en/asset-class/technology#507

Formerly Poalim Capital Markets

Institutional Investor

Tech Verticals Preferences

FinTech Artificial Intelligence, Big Data, Cyber Security, Deep Tech, Defense Tech, Digital Wallet, Energy Tech, Healthcare IT, Insurtech, Military, Mobile Applications, Payments, PayTech, Wireless communication

General Data

Established	1990
Current Active Portfolio Companies:	38
Reg. Number:	abCDe

DESCRIPTION

Poalim Equity is Bank Hapoalim’s investment platform. It invests across various sectors, geographies and strategies while providing comprehensive solutions throughout the entire companies’ life-cycle. As a merchant bank, Poalim Equity offers advisory services addressing its clients’ financial needs.

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
		Bank HaPoalim Ltd.
CB30EC75-B4A5-EB11-B80B-00505695CD29	Division	Bank Hapoalim Innovation & Strategic Investments Operation	Bank HaPoalim Ltd.
B7FFCB5C-207A-E111-AC59-00155D32A403	Investment Arm	Poalim Hi-Tech - Bank Hapoalim BM	Bank HaPoalim Ltd.
DDAE34EC-0A99-E111-AD2F-00155D32A403	Investment Arm	Poalim FinTech	Bank HaPoalim Ltd.
96D4D356-207A-E111-AC59-00155D32A403	Subsidiary	Poalim Equity	Bank HaPoalim Ltd.
E057965F-7538-E711-80D5-00155D0B8329	Subsidiary	Bank Hapoalim BM (BHI USA)	Bank HaPoalim Ltd.
E87728A0-1CA8-EF11-B817-9319F1798F89	Subsidiary	Poalim Tech	Bank HaPoalim Ltd.

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	46 Rothschild Blvd., Alrov Tower, 7th Floor
City	Tel Aviv
Country	Israel
Zip	6688312

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Ms. Liat Hazout	CEO	Canaf (Clal) (Head of Private Debt & Alternative Investments)
Mr. Eran Gersht	Managing Director, Head of Direct Investments	Poalim Ventures Ltd. (Managing Director)
Mr. Koby Kehaty	Managing Director, Head of Alternatives & Strategic Partnerships	Harel Insurance Investments and Financial Services (Group) (Head of Private Equity Investments)
Mr. Etai Kramer	Managing Director, Head of Tech Investments & Investment Banking	OurCrowd (Managing Director Co-Head, Funds)
Mr. Guy Goren	VP, Direct Investments
Mr. Eyal Issaharov	Director, Direct Investments
Mr. Dan Cohen	CFO
Ms. Eti Shlomo	Managing Director of IT, Operations & HR
Ms. Irit Frischer	General Counsel	Poalim Ventures Ltd. (General Counsel)
Ms. Hadas Segal	Head of Marketing & Value Creation	Poalim Ventures Ltd. (VP, Investor Relations & Marketing)

	Acquisitions made by Poalim Equity

Acquired Company	Sector	Date	Amount	Remarks
abC Defghij	N/A	Jul. 06, 2021	abCDe	30% of the company's shares were acquired, but Tene received a majority on the board and 51% of the voting rights. The company received $30m and the rest went to owners Jules and Eddie Trump.
abC Defghij	Biomed...	Oct. 28, 2020	abCDe	FIMI and institutional investors purchased 90% of the company from the Sackler family (73%), the Reshef family (3%) and the Levin family (14%) for NIS 630m. FIMI holds 78% of the shares, the institutional investors hold 12% and the Levin family holds 10%.
abC Defghij	N/A	Aug. 14, 2018	abCDe	Kedma and Poalim Capital Markets purchased 100% of the company together for around $100m.

Investment Data

Capital Remarks

Poalim Equity engages in: Direct Investments: investing in Israeli-related companies in various sectors with the ability to execute complex equity and debt transactions across the capital structure. Direct Investment Syndications Alternative Investments Investment Banking

Preferences

Type of Financing	Equity,Investments in Funds
Stage Preferences	Initial Revenues,Revenue Growth

SECTOR SEGMENTATION (By Number Of Companies)

Enterprise Software & Infrastructure

60%

Network Infrastructure

Consumer-Oriented Software

Digital Health

Agritech

Biomed

Cleantech

Semiconductors

Medical Devices

	PORTFOLIO COMPANIES

Current Portfolio Companies (38)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

AI21

Ent. SW

Third Round - Extended

21/11/2023

N/A

$53m

Amal Group

N/A

Secondary Deal

02/01/2024

$80m

Purchased 20% of the company for NIS 300m from FIMI and Dalia Korkin.

Assured Allies

Dig. Health

Second Round - Extended

07/03/2023

N/A

$21.5m

Autonomous Guard

N/A

Other

31/12/2006

N/A

In exchange for debt.

BeeHero

Agri

Third Round

01/12/2024

N/A

$30m

Debt Financing

Biomedix

N/A

Other

01/01/2005

N/A

Buildots

Ent. SW

Fourth Round - Extended	29/05/2025	$3m	$45m
Fourth Round	11/07/2024	N/A	$15m

Corvus

Ent. SW

Third Round - Extended

26/05/2021

N/A

$115m

Cross River Bank

N/A

Second Round

01/12/2018

N/A

$100m

DriveNets

Network Infra.

First Round - Extended

08/07/2019

N/A

$7m

DustPhotonics

Network Infra.

Second Round - Extended	21/02/2024	N/A	$24m
Second Round - Extended	28/10/2021	N/A	$33m

GlassBox

Ent. SW

Fourth Round	05/08/2025	N/A	N/A
Fourth Round	05/08/2025	N/A	N/A

GlassesUSA

CO SW

Second Round

01/10/2017

N/A

$25m

Hailo

Semicon.

Third Round - Extended	29/02/2024	N/A	$120m
Third Round	23/06/2021	$8m	$136m

Hoddesdon Energy

N/A

Straight Equity

25/02/2015

N/A

$90m

Holmes Place

N/A

Straight Equity

12/09/2016

$6.6m

$13.2m

Holds 18% of the company.

Keystone Dental

Second Round

06/01/2019

N/A

$20m

Kissterra

Ent. SW

First Round - Extended	16/05/2022	$10m	$10m
First Round	15/07/2021	N/A	$66m

Lendbuzz

Ent. SW

Venture Lending

29/05/2018

N/A

$33m

Lightico

Ent. SW

Second Round - Extended

19/07/2021

N/A

$14m

Logz.io

Ent. SW

Fifth Round - Extended

04/06/2024

N/A

Medcon Telemedicine Technology Ltd. (now McKesson...

Medcon is a global leader in cardiac image and information management solutions, devoted exclusively to optimizing the quality and cost-effectiveness of healthcare. Medcon ensures rapid access to complete and accurate images and information over local or remote networks, so cardiologists can provide the ultimate in care to patients.

Dig. Health

Other		N/A	N/A	Bank Hapoalim Mutual Funds, hold 5% of the company
Other		N/A	N/A	Bank Hapoalim Mutual Funds, hold 5% of the company

MeMed

Biomed

Fourth Round

01/11/2021

N/A

$93m

Mend.io

Ent. SW

Fifth Round	01/10/2022	N/A	N/A
Fourth Round	07/04/2021	N/A	$75m

Neema

CO SW

Second Round

03/01/2022

N/A

$17.7m

Otoma

Ent. SW

First Round

01/12/2018

N/A

$8m

Poalim FinTech

N/A

Investment in Fund

20/03/2012

N/A

$20m

Rav-Bariach (RB Group)

N/A

Straight Equity

20/10/2015

$13m

Holds 20% of the company.

Rplace

Cln.

Seed

01/06/2022

N/A

$0.015m

Salt of The Earth

N/A

Secondary Deal

29/08/2021

$47m

Purchased 20% of the company from Fortissimo for NIS 150m.

Sensos

Ent. SW

First Round

01/09/2023

N/A

$12.5m

Silk

Ent. SW

Seventh Round

07/07/2021

N/A

$55m

Sun Israel Clal

N/A

Straight Equity

01/09/2012

N/A

$5m

Teledata Communications (now ADC...

Network Infra.

Other		N/A	N/A
Other		N/A	N/A

ThetaRay

Ent. SW

Fourth Round	05/09/2023	N/A	$57m
Third Round - Extended	18/05/2021	N/A	$31m
Third Round	03/07/2018	N/A	$30m
Second Round	01/12/2015	N/A	$15m
First Round - Extended	29/07/2014	N/A	$10m
First Round - Extended	28/01/2014	$2.5m	$2.5m

Unqork

Ent. SW

Third Round

21/11/2020

N/A

$200m

Welland Biopower

N/A

Straight Equity

17/03/2015

N/A

$75m

WonderNet

Ent. SW

First Round

30/08/2001

$0.5m

Holds 5% of the company

Current VC Fund Portfolio (56)

Fund Name

Fund Type

Date Announced

Amount

Remarks

10D Fund II

Venture Capital Fund

28/02/2022

N/A

10D Opportunity I

Venture Capital Fund

01/10/2022

N/A

AMI Opportunities I

Private Equity Fund

27/11/2014

$25m

aMoon MN

Venture Capital Fund

01/09/2016

N/A

Canaan Israel I

Venture Capital Fund

01/09/2014

N/A

Delta I

Venture Capital Fund

01/01/1999

$12m

DOR

Venture Capital Fund

01/01/2000

N/A

Entrée Capital...

Venture Capital Fund

18/01/2022

N/A

FIMI III

Private Equity Fund

01/01/2005

N/A

FIMI IV

Private Equity Fund

01/01/2007

N/A

FIMI V

Private Equity Fund

27/06/2012

N/A

FIMI VI

Private Equity Fund

03/02/2016

$50m

FinTLV I

Venture Capital Fund

01/09/2018

N/A

FinTLV II

Venture Capital Fund

31/01/2021

$10m

Firstime I

Venture Capital Fund

01/05/2014

N/A

Firstime II

Venture Capital Fund

10/01/2017

N/A

Firstime III

Venture Capital Fund

01/02/2021

N/A

Fortissimo II

Private Equity Fund

01/10/2008

N/A

Fortissimo III

Private Equity Fund

01/07/2012

N/A

Giza III

Venture Capital Fund

01/01/2000

N/A

Glilot Capital IV

Venture Capital Fund

01/03/2022

N/A

Grove Ventures I

Venture Capital Fund

23/12/2015

N/A

Grove Ventures II

Venture Capital Fund

17/02/2020

N/A

Grove Ventures III

Venture Capital Fund

06/01/2022

N/A

Hanaco Growth III

Venture Capital Fund

01/01/2022

N/A

Hanaco Ventures III

Venture Capital Fund

01/03/2022

N/A

Hyperion

Venture Capital Fund

01/01/2000

N/A

Inimiti I

Venture Capital Fund

01/07/2012

N/A

ISF II

Secondary Fund

15/02/2016

N/A

ISF III

Secondary Fund

01/04/2022

N/A

Katzir Fund

Private Equity Fund

01/01/2006

N/A

Klirmark...

Private Equity Fund

18/12/2014

N/A

lool III

Venture Capital Fund

01/01/2022

N/A

Medica III

Venture Capital Fund

01/01/2005

$20m

Noy Fund

Private Equity Fund

01/05/2011

$25m

15%

Noy Fund II

Private Equity Fund

01/01/2015

N/A

Peregrine IV

Venture Capital Fund

01/01/2019

N/A

Pitango III

Venture Capital Fund

01/01/2000

N/A

Pontifax IV

Venture Capital Fund

14/12/2015

N/A

Pontifax V

Venture Capital Fund

01/01/2018

N/A

Pontifax VI

Venture Capital Fund

11/08/2020

N/A

SKY III

Private Equity Fund

04/01/2017

$20m

SKY IV

Private Equity Fund

12/01/2022

N/A

StageOne IV

Venture Capital Fund

01/01/2022

N/A

Star Israel

Venture Capital Fund

01/01/1992

N/A

TLV Partners II

Venture Capital Fund

06/02/2018

N/A

TPY Capital II

Venture Capital Fund

01/05/2018

N/A

UpWest

Venture Capital Fund

01/09/2017

N/A

Vertex VI

Venture Capital Fund

01/01/2021

N/A

vgames Fund

Venture Capital Fund

01/07/2020

N/A

Vintage Secondary...

Secondary Fund

05/06/2013

N/A

Viola Fintech I

Venture Capital Fund

06/12/2017

$15m

Viola Growth IV

Venture Capital Fund

01/02/2023

N/A

Viola Ventures I

Venture Capital Fund

01/01/2000

N/A

Yozma II

Venture Capital Fund

01/01/1998

$16m

Yozma III

Venture Capital Fund

01/01/2001

N/A

Exits (22)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	01/09/2023	abCDe	NIS 487m
abC Defghij	Acquired	20/02/2019	abCDe	NIS 842m
abC Defghij	IPO	19/06/2017	abCDe	09/2019: Delisted following acquisition by RAFAEL and Avichai Stolero.
abC Defghij	Acquired	28/10/2021	abCDe
abC Defghij (Investment Company)	Acquired	19/07/2001	abCDe	In a share swap
abC Defghij	Holdings Sold		abCDe
abC Defghij	Acquired	29/09/2021	abCDe	In cash.
abC Defghij	IPO	02/08/2021	abCDe	SPAC Deal
abC Defghij	Acquired	11/09/2011	abCDe	A share-swap deal.
abC Defghij	Acquired	15/02/2022	abCDe	Acquired by Nintex, a portfolio company of Thoma Bravo.
abC Defghij (Private Equity Fund)	IPO	06/04/2017	abCDe
abC Defghij	Acquired	01/07/2025	abCDe	In cash. ERGO Group is the primary insurance arm of Munich Re, a German multinational reinsurance company.
abC Defghij	IPO	22/06/2022	abCDe	SPAC deal with EJF Acquisition Corp alongside a PIPE deal. Investors in EJF Acquisition have pulled back their investments during its IPO, so the merger between it and Pagaya did not generate any money. Pagaya's proceeds came solely from the PIPE deal ($350m).
abC Defghij	Acquired	11/12/2024	abCDe	$34m in cash.
abC Defghij	IPO	22/07/2021	abCDe	SPAC deal
abC Defghij	Acquired	17/12/2020	abCDe
abC Defghij	Holdings Sold	08/04/2021	abCDe
abC Defghij	Acquired	24/04/2024	abCDe
abC Defghij	IPO	12/09/2025	abCDe	The IPO included shares sold directly by the company and shares sold by existing shareholders. The total amount received for all shares was $493m. The company earned $329m.
abC Defghij	IPO	17/09/2021	abCDe	Raised AUD 7m; Valuation AUD 30.m
abC Defghij (Investment Company)	Acquired	01/03/2001	abCDe	$22 million in cash and $8m in shares
abC Defghij	Acquired	01/07/2021	abCDe

Historic Portfolio (20)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Challenge II

N/A

Investment in Fund

01/01/1999

N/A

ComfyNet

Ceased to Operate

HW & Indust.

Other

N/A

Courses

N/A

Investment in Fund

01/01/1993

N/A

DayTwo

Ceased to Operate

Dig. Health

Third Round

31/05/2021

N/A

$37m

EarlySense

Ceased to Operate

Dig. Health

Seventh Round	01/09/2018	N/A	$39m
Sixth Round	01/06/2016	N/A	$25m

FIMI I

N/A

Investment in Fund

01/01/1996

N/A

$150m

FIMI II

N/A

Investment in Fund

01/01/2002

N/A

$200m

FITE I

Ceased to Operate

N/A

Investment in Fund

01/01/2004

N/A

Fortissimo I

N/A

Investment in Fund

01/04/2004

N/A

$80m

Gemini III

N/A

Investment in Fund

01/01/2000

N/A

$200m

Horizon

N/A

Investment in Fund

01/01/1993

N/A

Markstone I

N/A

Investment in Fund

01/06/2004

$5m

$786m

Poalim Venture Services (PVS)

Ceased to Operate

N/A

Other

01/01/2000

N/A

Poalim Ventures

N/A

Investment in Fund

01/01/1998

N/A

Poalim Ventures I

N/A

Investment in Fund

01/01/2000

N/A

Poalim Ventures II

N/A

Investment in Fund

01/01/2000

N/A

SFT

Ceased to Operate

N/A

Other

01/01/2000

N/A

Vertex II

N/A

Investment in Fund

01/01/2000

N/A

$160m

Walden III

N/A

Investment in Fund

01/01/2001

N/A

Yes To Carrots

Ceased to Operate

Biomed

First Round

29/07/2008

N/A

$14m

Last Updated:	abCDe
IVC Number:	abCDe